Crossmark

Intravitreal bevacizumab: Is it exempt from adverse extraocular effects?

Crossref DOI link: https://doi.org/10.1016/j.rceng.2018.12.010

Published Print: 2019-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sánchez López, M.

Navarro Puerto, M.A.

Gutiérrez Morales, I.
License Information

Text and Data Mining valid from 2019-05-01
More Information

This article is maintained by: Elsevier

Article Title: Intravitreal bevacizumab: Is it exempt from adverse extraocular effects?

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2018.12.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2018.12.005

Content Type: simple-article

Copyright: © 2019 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.